Aspen Aerogels (ASPN) Misses Q2 EPS by 6c

Aspen Aerogels (NYSE: ASPN) reported Q2 EPS of ($0.29), $0.06 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $21.7 million versus the consensus estimate of $25.45 million.

GUIDANCE:

Aspen Aerogels sees FY2018 EPS of ($0.87)-($0.95), versus the consensus of ($0.83). Aspen Aerogels sees FY2018 revenue of $102-112 million, versus the consensus of $111.46 million.

For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance
• H.C. Wainwright Reiterates Buy Rating on Incyte (INCY)